G
G. Varadi
Researcher at Hebrew University of Jerusalem
Publications - 24
Citations - 2776
G. Varadi is an academic researcher from Hebrew University of Jerusalem. The author has contributed to research in topics: Transplantation & Stem cell. The author has an hindex of 12, co-authored 23 publications receiving 2758 citations.
Papers
More filters
Journal ArticleDOI
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
Shimon Slavin,Arnon Nagler,Ella Naparstek,Yossi Kapelushnik,Memet Aker,Gabriel Cividalli,G. Varadi,Mark Kirschbaum,Aliza Ackerstein,Simcha Samuel,Avraham Amar,Chaim Brautbar,Ofira Ben-Tal,Amiram Eldor,Reuven Or +14 more
TL;DR: Preliminary data in 26 patients with standard indications for allogeneic BMT suggest that nonmyeloablative conditioning including fludarabine, anti-T-lymphocyte globulin, and low-dose busulfan is extremely well tolerated, with no severe procedure-related toxicity.
Journal ArticleDOI
Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma
TL;DR: Results suggest that alloSCT following fludarabine-based low intensity conditioning in high-risk patients merits further evaluation, and fast engraftment and minimal transplant-related toxicity are reported.
Journal ArticleDOI
Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation
Arnon Nagler,Memet Aker,Reuven Or,Elizabeth Naparstek,G. Varadi,Chaim Brautbar,Shimon Slavin +6 more
TL;DR: These results indicate that low-intensity conditioning is sufficient to ensure stable engraftment of bone marrow grafts in a matched unrelated setting.
Journal ArticleDOI
Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen
Shoshana Morecki,Y Gelfand,Arnon Nagler,Reuven Or,Ella Naparstek,G. Varadi,Dan Engelhard,A. Akerstein,S. Slavin +8 more
TL;DR: In this article, the authors investigated the immune status of patients with hematologic malignancies treated with a low intensity conditioning in preparation for allogeneic stem cell transplantation, which resulted in rapid engraftment and complete replacement of host with donor hematopoietic cells.
Immune reconstitution Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen
TL;DR: It is hypothesized that clinical application of NST may lead to faster development of effective immune responses against residual host-type malignant and abnormal non-malignant hematopoietic cells, although the role of fludarabine on post-transplant infections remains to be investigated in a larger cohort of patients.